Archives: Technologies

Application Our Innovation An innovative VR product, based on state-of-the-art AI tools, which provide extremely high-quality applications including speech-to-text, text analysis and creation and text-to-speech. Advantages Opportunity The distinctive features of our project are designed to appeal to companies specializing in mental health solutions, virtual therapy, and educational technology, by offering a versatile tool that […]...

Application Our Innovation Our novel dual-layer coating promises up to 99.5% efficiency in protecting large-scale iron and steel surfaces from corrosion. The coating consists of two interconnected layers: The NHC layer functions as a double-sided organic glue, resulting in strong adhesion of the secondary film coating to the iron surface. This unique combination enables exceptional […]...

Application Synthetic data generation from private source data is a prominent and lofty goal that has been the focus of multiple prior work. A prevalent line of work relies on Differential Privacy (DP) in the data generation process. DP is considered the gold-standard for guaranteeing data privacy, allowing for desired theoretical guarantees. Due to these […]...

Application Our Innovation Advantages Opportunity We propose a new process learning framework that is applied to flood forecasting. This approach can be extended to other disciplines. We seek collaborations with stakeholders interested in flood forecasting with an integrative view that combines predictability and process understanding....

Application Our Innovation We developed a 3D-printing method that utilizes photopolymerizable sol-gel technology with soluble metal salts precursors, resulting in the fabrication of objects with controlled porosity and transparency. Advantages Opportunity Our technology has multiple potential applications, such as high-precision ceramic parts for the aerospace and defense industry, advanced ceramic implants for orthopedic and dental […]...

Application Point mutations in the genes HNRNPH2 and PCDH19 each cause a rare childhood neurodevelopmental disease. These diseases are characterized by developmental and intellectual retardation, muscle hypotonia, autism spectrum disorders, and severe epileptic seizures. Both genes are located on the X chromosome, and the disease is manifested in a heterozygous setting (in females) or mosaic […]...

Application:           Our innovation: Our innovation consists of: 1.           A software system for clinical decision support for the pharma companies (algorithms and UI), 2.           Automated generation of hypotheses/insights toward future development of novel combination therapies. Our goal is to predict which drug combinations are beneficial for specific populations of patients. Advantages: Opportunity: Our technology will serve […]...

Application Our Innovation This technology suggests novel methodologies to detect IT resistant patients and means of novel combination treatments to potentiate IT, based on our finding that cathepsin activity is elevated in tumor tissue from melanoma patients and animal models that are resistant to immunotherapy (IT). Advantages Opportunity...

Application Our Innovation A novel treatment for musculoskeletal conditions, based on novel highly selective covalent irreversible inhibitors targeted to cathepsin K and selective covalent reversible and covalent irreversible activity-based probes. A subset of the inhibitors we designed can be linked to targeting moiety to reduce adverse effects and therefore serves as candidate drugs for postmenopausal […]...

Prof. Chaim Gilon, The Hebrew University of JerusalemProf. Prof. Rachel Bar-Shavit, Hadassah Medical Center Application Our Innovation We develop and characterize a “lead cyclic peptidomimetic” compound of PAR4-PH binding domain for available cancer drug. Advantages Opportunity The opportunity for developing an efficient drug that will potently inhibit breast cancer stem cells and is expected also […]...